These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 30416002)
21. Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastasis using arterial spin labeling and dynamic contrast-enhanced magnetic resonance imaging. Xi YB; Kang XW; Wang N; Liu TT; Zhu YQ; Cheng G; Wang K; Li C; Guo F; Yin H Eur J Radiol; 2019 Mar; 112():59-64. PubMed ID: 30777220 [TBL] [Abstract][Full Text] [Related]
22. Dynamic contrast-enhanced and diffusion-weighted MRI of cervical carcinoma: Correlations with Ki-67 proliferation status. Lai B; Yi Y; Yang X; Li X; Xu L; Yan Z; Yang L; Han R; Hu H; Duan X Magn Reson Imaging; 2024 Oct; 112():136-143. PubMed ID: 39029603 [TBL] [Abstract][Full Text] [Related]
23. Correlation Between Apparent Diffusion Coefficient and the Ki-67 Proliferation Index in Grading Pediatric Glioma. Yao R; Cheng A; Zhang Z; Jin B; Yu H J Comput Assist Tomogr; 2023 Mar-Apr 01; 47(2):322-328. PubMed ID: 36957971 [TBL] [Abstract][Full Text] [Related]
24. Non-Invasive Estimation of Glioma Hu Y; Chen Y; Wang J; Kang JJ; Shen DD; Jia ZZ Front Oncol; 2020; 10():593102. PubMed ID: 33425744 [TBL] [Abstract][Full Text] [Related]
25. Intergrating conventional MRI, texture analysis of dynamic contrast-enhanced MRI, and susceptibility weighted imaging for glioma grading. Su CQ; Lu SS; Han QY; Zhou MD; Hong XN Acta Radiol; 2019 Jun; 60(6):777-787. PubMed ID: 30244590 [TBL] [Abstract][Full Text] [Related]
26. Application of Distributed Parameter Model to Assessment of Glioma IDH Mutation Status by Dynamic Contrast-Enhanced Magnetic Resonance Imaging. Li Z; Zhao W; He B; Koh TS; Li Y; Zeng Y; Zhang Z; Zhang J; Hou Z Contrast Media Mol Imaging; 2020; 2020():8843084. PubMed ID: 33299387 [TBL] [Abstract][Full Text] [Related]
27. Comparison of T1 mapping and fixed T1 method for dynamic contrast-enhanced MRI perfusion in brain gliomas. Conte GM; Altabella L; Castellano A; Cuccarini V; Bizzi A; Grimaldi M; Costa A; Caulo M; Falini A; Anzalone N Eur Radiol; 2019 Jul; 29(7):3467-3479. PubMed ID: 30972545 [TBL] [Abstract][Full Text] [Related]
28. Quantitative analysis of permeability for glioma grading using dynamic contrast-enhanced magnetic resonance imaging. Zhao M; Guo LL; Huang N; Wu Q; Zhou L; Zhao H; Zhang J; Fu K Oncol Lett; 2017 Nov; 14(5):5418-5426. PubMed ID: 29113174 [TBL] [Abstract][Full Text] [Related]
29. Comparison of diffusion kurtosis imaging and dynamic contrast enhanced MRI in prediction of prognostic factors and molecular subtypes in patients with breast cancer. Wang W; Lv S; Xun J; Wang L; Zhao F; Wang J; Zhou Z; Chen Y; Sun Z; Zhu L Eur J Radiol; 2022 Sep; 154():110392. PubMed ID: 35679701 [TBL] [Abstract][Full Text] [Related]
30. Effects of arterial input function selection on kinetic parameters in brain dynamic contrast-enhanced MRI. Keil VC; Mädler B; Gieseke J; Fimmers R; Hattingen E; Schild HH; Hadizadeh DR Magn Reson Imaging; 2017 Jul; 40():83-90. PubMed ID: 28438713 [TBL] [Abstract][Full Text] [Related]
31. PDZK1 is correlated with DCE-MRI perfusion parameters in high-grade glioma. Zhang Y; Wang F; Huang Y Clinics (Sao Paulo); 2024; 79():100367. PubMed ID: 38692010 [TBL] [Abstract][Full Text] [Related]
32. Glioma: Application of histogram analysis of pharmacokinetic parameters from T1-weighted dynamic contrast-enhanced MR imaging to tumor grading. Jung SC; Yeom JA; Kim JH; Ryoo I; Kim SC; Shin H; Lee AL; Yun TJ; Park CK; Sohn CH; Park SH; Choi SH AJNR Am J Neuroradiol; 2014 Jun; 35(6):1103-10. PubMed ID: 24384119 [TBL] [Abstract][Full Text] [Related]
34. Low-grade and anaplastic oligodendrogliomas: differences in tumour microvascular permeability evaluated with dynamic contrast-enhanced magnetic resonance imaging. Jia Z; Geng D; Liu Y; Chen X; Zhang J J Clin Neurosci; 2013 Aug; 20(8):1110-3. PubMed ID: 23673143 [TBL] [Abstract][Full Text] [Related]
35. Dynamic Contrast-Enhanced MRI in Low-Grade Versus Anaplastic Oligodendrogliomas. Arevalo-Perez J; Kebede AA; Peck KK; Diamond E; Holodny AI; Rosenblum M; Rubel J; Gaal J; Hatzoglou V J Neuroimaging; 2016 May; 26(3):366-71. PubMed ID: 26707628 [TBL] [Abstract][Full Text] [Related]
36. Dynamic contrast-enhanced and diffusion-weighted MRI of estrogen receptor-positive invasive breast cancers: Associations between quantitative MR parameters and Ki-67 proliferation status. Shin JK; Kim JY J Magn Reson Imaging; 2017 Jan; 45(1):94-102. PubMed ID: 27313102 [TBL] [Abstract][Full Text] [Related]
37. Brain Glioma Localization Diagnosis Based on Magnetic Resonance Imaging. Jin Y; Peng H; Peng J World Neurosurg; 2021 May; 149():325-332. PubMed ID: 32992057 [TBL] [Abstract][Full Text] [Related]
38. Histogram analysis of T2*-based pharmacokinetic imaging in cerebral glioma grading. Liu HS; Chiang SW; Chung HW; Tsai PH; Hsu FT; Cho NY; Wang CY; Chou MC; Chen CY Comput Methods Programs Biomed; 2018 Mar; 155():19-27. PubMed ID: 29512499 [TBL] [Abstract][Full Text] [Related]
39. An initial study on the predictive value using multiple MRI characteristics for Ki-67 labeling index in glioma. Du N; Shu W; Li K; Deng Y; Xu X; Ye Y; Tang F; Mao R; Lin G; Li S; Fang X J Transl Med; 2023 Feb; 21(1):119. PubMed ID: 36774480 [TBL] [Abstract][Full Text] [Related]
40. Is volume transfer coefficient (K(trans)) related to histologic grade in human gliomas? Patankar TF; Haroon HA; Mills SJ; Balériaux D; Buckley DL; Parker GJ; Jackson A AJNR Am J Neuroradiol; 2005; 26(10):2455-65. PubMed ID: 16286385 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]